Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
short squeeze all day | jedijazz | investorshub | 04/27/2023 11:17:06 PM |
Price trading | conix | investorshub | 04/27/2023 9:40:57 PM |
$IKT Long and strong lets hope im right | TrendTrade2016 | investorshub | 04/27/2023 2:06:36 PM |
$IKT Price trading | estreet7883 | investorshub | 04/27/2023 3:50:09 AM |
$IKT Time for a bounce? | conix | investorshub | 04/27/2023 2:47:45 AM |
$IKT MomentumIts now up | conix | investorshub | 04/27/2023 12:40:58 AM |
Price trading | jedijazz | investorshub | 04/26/2023 10:58:11 PM |
MomentumIts now up | ProfitScout | investorshub | 04/26/2023 3:23:45 PM |
Price now up | heyitsmeagain | investorshub | 04/26/2023 1:55:46 PM |
$IKT Anyone hear anything lately? Want to see this one go | conix | investorshub | 04/26/2023 11:34:23 AM |
MomentumIts gaining | conix | investorshub | 04/26/2023 11:02:13 AM |
short squeeze | jedijazz | investorshub | 04/26/2023 4:53:33 AM |
$IKT Price trading | conix | investorshub | 04/26/2023 4:26:48 AM |
$IKT Price trading last up | budfoxfun | investorshub | 04/26/2023 4:05:52 AM |
Price now last up | conix | investorshub | 04/26/2023 3:38:52 AM |
$IKT MomentumIts now | conix | investorshub | 04/26/2023 3:33:39 AM |
great article | conix | investorshub | 04/26/2023 2:01:57 AM |
$IKT short squeeze | estreet7883 | investorshub | 04/25/2023 10:57:17 PM |
$IKT MomentumIts trading | conix | investorshub | 04/25/2023 9:38:55 PM |
best news of the day | TrendTrade2016 | investorshub | 04/25/2023 1:51:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...